Clinical Research Pharma Companies Trials 
Vial
FEBRUARY 15, 2024
Clinical trials play a crucial role in advancing medical breakthroughs, but effective management is essential to unlock their full potential. Pharmaceutical companies often face challenges in conducting clinical trials due to the need for substantial knowledge, time, and resources.
PPD
JULY 13, 2023
Site and patient recruitment vendors are vital in supporting clinical trial operations across all phases and therapeutic areas. Their services help engage a suitable participant pool, facilitate clinical trial participation, ensure that selected sites have the resources to support clinical trial activities and more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
OCTOBER 16, 2020
As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. BetterLife conducts patient centric study via a fully remote clinical trial.
H1 Blog
JULY 30, 2024
Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research.
H1 Blog
JUNE 26, 2024
In a recent interview, Daniel Perez, the Director and Global Head of Health Equity for Worldwide Clinical Trials shared insights on health equity from personal and professional experiences. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.
Quanticate
OCTOBER 16, 2020
Gathering all the heterogenous data and mapping to the internal standards of the pharma companies proved to be the greatest challenge of the time. By the end of 2007, and towards the beginning of 2008, the Clinical Data Interchange Standards Consortium (CDISC) gained ground in its mission to develop a global set of standards.
Advarra
JUNE 14, 2022
Often, low accrual or delays in clinical trials stem from an undersized pipeline of potential participants. When site staff must manually find participants for trials, or even when automated recruitment solutions don’t deliver as promised, it puts the trial’s viability at stake, with sites and sponsors in the hot seat.
Expert insights. Personalized for you.
52 
Let's personalize your content